- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Neoplasms in Russian Federation
Total 1787 results
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
SandozSandoz GmbHCompletedBreast Neoplasms | Chemotherapeutic Toxicity | Chemotherapy-induced Neutropenia | Neutropenic ComplicationsRussian Federation, Brazil, India, Mexico, Romania, Ukraine
-
IpsenCompleted
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
Hoffmann-La RocheChugai PharmaceuticalCompletedBreast CancerKorea, Republic of, Canada, Brazil, Germany, Italy, Spain, Japan, Czechia, Poland, United States, Russian Federation, Taiwan
-
Hoffmann-La RocheCompletedBreast CancerItaly, Korea, Republic of, Spain, Taiwan, United Kingdom, Brazil, Russian Federation, Thailand, Israel, Turkey, Austria, Canada, Poland, Sweden, Australia, Peru, Switzerland, Mexico
-
AB ScienceCompletedOvarian CancerFrance, United Kingdom, Ukraine, Algeria, Russian Federation, Spain
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
PfizerCompletedBreast CancerKorea, Republic of, United States, Spain, Germany, Ireland, Hungary, Canada, France, Italy, Russian Federation, South Africa, Ukraine
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsRussian Federation, Hungary, Moldova, Republic of, Poland
-
Mylan Inc.Mylan GmbHCompletedBreast CancerSlovakia, Brazil, Chile, Georgia, Hungary, India, Latvia, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
-
SanofiCancer International Research Group (CIRG)CompletedBreast NeoplasmsUnited States, France, Brazil, Romania, Russian Federation, Australia, Spain, Sweden, Turkey, India, Slovakia, Taiwan, Belgium, Czech Republic, Tunisia, Uruguay, Argentina, Croatia, Austria, Egypt, Greece, Hungary, Ireland, Israel, Italy, Mexic... and more
-
SandozSandoz GmbHCompletedBreast Cancer | Chemotherapy-induced NeutropeniaSpain, United States, Argentina, Chile, India, Malaysia, Puerto Rico, Russian Federation
-
Pierre Fabre MedicamentCompletedBreast Cancer | MetastasesFrance, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
-
Sopherion TherapeuticsUnknownBreast CancerCanada, Spain, United States, United Kingdom, Poland, Germany, India, Italy, Argentina, Portugal, Russian Federation
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedBreast CancerCanada, Germany, Korea, Republic of, Panama, Spain, Turkey, Brazil, Colombia, France, Hungary, Russian Federation, Taiwan, Thailand, Czechia, Italy, Estonia, Peru, South Africa, Sweden, Poland, Israel, Hong Kong, Mexico, Guatemala, Arge... and more
-
AstraZenecaTerminatedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Czech Republic, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, South Africa, United Kingdom, Philippines, Ukraine, Finland, Canada, Taiwan, India, Thailand, United States, Japan
-
Intarcia TherapeuticsCompletedBreast Neoplasms | Neoplasms, Hormone-dependentUnited States, Canada, Russian Federation, Ukraine
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
Eli Lilly and CompanyCompletedFallopian Tube Neoplasms | Ovarian Cancer | Peritoneal NeoplasmSpain, Poland, Belgium, Russian Federation, Germany
-
Hoffmann-La RocheCompletedBreast NeoplasmsFrance, Spain, Sweden, Denmark, Russian Federation, Canada, Germany, United Kingdom, Italy, Turkey, Poland, Switzerland
-
Pierre Fabre MedicamentCompletedBreast CancerFrance, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
AstraZenecaActive, not recruitingBreast CancerBelgium, Spain, Italy, United States, Brazil, Czechia, Russian Federation, Chile, Slovakia, Hungary, India, Ukraine, Venezuela, Colombia, Poland, Malta, Mexico
-
Hoffmann-La RocheCompletedBreast NeoplasmsCanada, United States, France, Korea, Republic of, Spain, Belgium, Germany, Russian Federation, Taiwan, Ukraine
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, France, Taiwan, Hungary, Germany, Singapore, Austria, Netherlands, Australia, Russian Federation, Spain, Canada, Israel, Japan, Korea, Republic of, Italy, United States, United Kingdom, Brazil, Hong Kong, Czech Republic, South...
-
TakedaCompletedCancer | Break Through PainRussian Federation, Hungary, Norway
-
ValexfarmCompletedEpilepsy | Complex Partial Seizures | Simple Partial Seizures | Partial Seizures With Secondary GeneralizationRussian Federation
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Russian Federation, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Finland, Peru, Colombia, Portugal, Canada, Brazil, India, Argentina, Costa Rica
-
OBI Pharma, IncRecruitingTriple Negative Breast CancerChina, Taiwan, United States, Korea, Republic of, Australia, Brazil, Hong Kong, Mexico, Russian Federation, South Africa, Ukraine, Peru, Poland
-
Benitec BioPharma LtdCompletedHead and Neck Squamous Cell CarcinomaAustralia, Russian Federation
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis Type 1United States, Spain, Poland, Russian Federation
-
Hoffmann-La RocheTerminatedLymphocytic Leukemia, ChronicRussian Federation
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Novartis PharmaceuticalsActive, not recruitingTriple Negative Breast NeoplasmsFrance, Italy, Croatia, Taiwan, Australia, Argentina, Korea, Republic of, China, Israel, Russian Federation, Slovakia, Slovenia, United Kingdom, Germany, Mexico, Switzerland, Spain, Brazil, Hungary, Malaysia, South Africa, Austria, ... and more
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Janssen Research & Development, LLCCompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell NeoplasmUnited States, Belgium, Russian Federation
-
Hoffmann-La RocheCompletedBreast CancerChina, United States, South Africa, Russian Federation, Thailand, Bosnia and Herzegovina, Czech Republic, India, Poland
-
Hoffmann-La RocheActive, not recruitingMetastatic Breast CancerKorea, Republic of, United Kingdom, Australia, China, Croatia, Finland, France, Norway, Portugal, Slovenia, Canada, Italy, Spain, Colombia, Brazil, Poland, United States, Greece, Turkey, Russian Federation, Philippines
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
Janssen Research & Development, LLCCompletedB-Cell Chronic Lymphocytic LeukemiaSpain, Russian Federation, Canada
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell CarcinomaChina, Argentina, Brazil, Russian Federation, Bulgaria, United States